Townsquare Capital LLC Has $7.82 Million Stake in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Key Points

• Townsquare Capital LLC increased its position in Prestige Consumer Healthcare by 5.0%, now holding 91,002 shares valued at approximately $7.82 million.
• Prestige Consumer Healthcare's stock is down 3.0%, with the company reporting earnings of $0.95 per share, missing estimates by $0.06, and experiencing a 6.6% decline in revenue year-over-year.
• Analyst ratings on Prestige Consumer Healthcare vary, with four firms rating it as a "hold" while three provide a "buy" rating, indicating mixed sentiment among investors.

Townsquare Capital LLC grew its stake in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 5.0% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 91,002 shares of the company's stock after purchasing an additional 4,318 shares during the period. Townsquare Capital LLC owned about 0.18% of Prestige Consumer Healthcare worth $7,823,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently bought and sold shares of PBH. Citigroup Inc. boosted its position in shares of Prestige Consumer Healthcare by 21.6% during the 1st quarter. Citigroup Inc. now owns 105,428 shares of the company's stock valued at $9,064,000 after acquiring an additional 18,759 shares in the last quarter. Neumeier Poma Investment Counsel LLC acquired a new stake in shares of Prestige Consumer Healthcare during the 1st quarter valued at about $8,713,000. Charles Schwab Investment Management Inc. boosted its position in shares of Prestige Consumer Healthcare by 1.0% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 642,390 shares of the company's stock valued at $55,226,000 after acquiring an additional 6,370 shares in the last quarter. Westwood Holdings Group Inc. boosted its position in shares of Prestige Consumer Healthcare by 7.1% during the 1st quarter. Westwood Holdings Group Inc. now owns 861,282 shares of the company's stock valued at $74,044,000 after acquiring an additional 56,802 shares in the last quarter. Finally, Costello Asset Management INC acquired a new stake in shares of Prestige Consumer Healthcare during the 1st quarter valued at about $112,000. 99.95% of the stock is currently owned by institutional investors and hedge funds.

Prestige Consumer Healthcare Price Performance

Shares of Prestige Consumer Healthcare stock traded up $0.49 during midday trading on Wednesday, reaching $65.80. The company had a trading volume of 269,997 shares, compared to its average volume of 380,702. The company has a current ratio of 4.38, a quick ratio of 2.99 and a debt-to-equity ratio of 0.55. The stock has a fifty day simple moving average of $78.43 and a 200 day simple moving average of $81.89. Prestige Consumer Healthcare Inc. has a 1-year low of $62.95 and a 1-year high of $90.04. The company has a market capitalization of $3.24 billion, a price-to-earnings ratio of 15.45, a price-to-earnings-growth ratio of 2.02 and a beta of 0.43.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The company reported $0.95 earnings per share for the quarter, missing the consensus estimate of $1.01 by ($0.06). Prestige Consumer Healthcare had a return on equity of 12.69% and a net margin of 19.02%. The company had revenue of $249.53 million during the quarter, compared to the consensus estimate of $260.71 million. During the same quarter last year, the firm earned $0.90 EPS. The business's revenue for the quarter was down 6.6% on a year-over-year basis. As a group, equities research analysts forecast that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current year.

Analyst Ratings Changes

Several brokerages have recently weighed in on PBH. Canaccord Genuity Group decreased their target price on shares of Prestige Consumer Healthcare from $105.00 to $100.00 and set a "buy" rating on the stock in a research report on Friday, August 8th. Royal Bank Of Canada upgraded shares of Prestige Consumer Healthcare to a "hold" rating in a research report on Thursday, May 8th. Finally, Wall Street Zen lowered shares of Prestige Consumer Healthcare from a "buy" rating to a "hold" rating in a research report on Saturday. Four analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and an average target price of $93.33.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.